Top compounds associated with response to TUBG2


Feature Type Standardized
Nominal ANOVA
mRNA Panobinostat CCLE pan-cancer AAC -0.091 0.03
mRNA JNJ-26854165 GDSC1000 pan-cancer AAC -0.082 0.03
mRNA AZD0530 CCLE pan-cancer AAC -0.1 0.03
mRNA QL-VIII-58 GDSC1000 pan-cancer AAC 0.11 0.03
mRNA lapatinib GDSC1000 pan-cancer AAC 0.12 0.03
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.077 0.03
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.08 0.03
mRNA rigosertib CTRPv2 pan-cancer AAC -0.073 0.03
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.07 0.04
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.069 0.04
Download CSV